Surgery: light – thermal – and electrical application – Light – thermal – and electrical application – Electrical therapeutic systems
Reexamination Certificate
2006-02-21
2011-10-11
Layno, Carl H (Department: 3766)
Surgery: light, thermal, and electrical application
Light, thermal, and electrical application
Electrical therapeutic systems
C607S002000, C607S040000, C607S116000, C607S118000, C607S133000
Reexamination Certificate
active
08036745
ABSTRACT:
A treatment method is provided, including identifying a subject as one who is selected to undergo an interventional medical procedure, and, in response to the identifying, reducing a likelihood of a potential adverse effect of the procedure by applying an electrical current to a parasympathetic site of the subject selected from the group consisting of: a vagus nerve of the subject, an epicardial fat pad of the subject, a pulmonary vein of the subject, a carotid artery of the subject, a carotid sinus of the subject, a coronary sinus of the subject, a vena cava vein of the subject, a jugular vein of the subject, a right ventricle of the subject, a parasympathetic ganglion of the subject, and a parasympathetic nerve of the subject.
REFERENCES:
patent: 5058599 (1991-10-01), Anderson
patent: 5139020 (1992-08-01), Koestner et al.
patent: 5615684 (1997-04-01), Hagel et al.
patent: 6058328 (2000-05-01), Levine et al.
patent: 6104956 (2000-08-01), Naritoku et al.
patent: 6195584 (2001-02-01), Hill et al.
patent: 6473644 (2002-10-01), Terry et al.
patent: 6522926 (2003-02-01), Kieval et al.
patent: 6571122 (2003-05-01), Schroeppel et al.
patent: 6622041 (2003-09-01), Terry et al.
patent: 6690971 (2004-02-01), Schauerte et al.
patent: 6885888 (2005-04-01), Rezai et al.
patent: 7136700 (2006-11-01), Province et al.
patent: 7403819 (2008-07-01), Shelchuk et al.
patent: 7509166 (2009-03-01), Libbus
patent: 7765000 (2010-07-01), Zhang et al.
patent: 2004/0172075 (2004-09-01), Shafer et al.
patent: 2006/0047325 (2006-03-01), Thimineur et al.
patent: 2006/0064140 (2006-03-01), Whitehurst et al.
patent: 2006/0149337 (2006-07-01), John
patent: 2006/0167498 (2006-07-01), DiLorenzo
patent: 2006/0259077 (2006-11-01), Pardo et al.
patent: WO 2006/102370 (2006-09-01), None
Armour, J. et al., (1994) “Neurocardiology”,Oxford University Presspp. 60-64.
Billette, J. et al., (1975) “Roles of the AV junction in determining the ventricular response to atrial fibrillation,”Canadian Journal of Physiology and Pharmacology53(4):575-85 (1975).
Borovikova, L. et al., (2000)“Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin,”Nature405(6785):458-62.
Cummings, J. et al., (2004) “Preservation of the anterior fat pad paradoxically decreases the incidence of postoperative atrial fibrillation in humans,”Journal of the American College of Cardiology43(6):994-1000.
De Ferrari, G. et al. (1991) “Vagal reflexes and survival during acute myocardial ischemia in conscious dogs with healed myocardial infarction,”American Journal of Physiology261(1 Pt 2):H63-9.
Feliciano, L et al., (1998) “Vagal nerve stimulation releases vasoactive intestinal peptide which significantly increases coronary artery blood flow, ”Cardiovascular Research40:45-55.
Garrigue, S. et al., (1998) “Post-ganglionic vagal stimulation of the atrioventricular node reduces ventricular rate during atrial fibrillation,” PACE 21(4, Part II):356.
Hayash,i H. et al., (1998) “Different effects of class Ic and III antiarrhythmic drugs on vagotonic atrial fibrillation in the canine heart,”Journal of Cardiovascular Pharmacology31:101-107.
Higgins, C., (1973) “Parasympathetic control of the heart,”Pharmacological Review25:120-155.
Jideus, L,. (2001) “Atrial fibrillation after coronary artery bypass surgery: A study of causes and risk factors,”Acta Universitatis Upsaliensis1-56.
Jones, J. et al., (1995) “Heart rate responses to selective stimulation of cardiac vagal C fibres in anaesthetized cats, rats and rabbits,”Journal of Physiology489 (1):203-14.
Kwan, H. et al., (2001) “Cardiovascular adverse drug reactions during initiation of antiarrhythmic therapy for atrial fibrillation,”Canadian Journal of HospitalPharmacy 54(1):10-14.
Li, D. et al., (1999) “Promotion of Atrial Fibrillation by Heart Failure in Dogs: Atrial Remodeling of a Different Sort,”Circulation100(1):87-95.
Lindmark, S. et al., (2003) “Does the autonomic nervous system play a role in the development of insulin resistance? A study on heart rate variability in first-degree relatives of type 2 diabetes patients and control subjects.”Diabetes Medicine20:399-405.
Martin, P. et al., (1983) “Phasic effects of repetitive vagal stimulation on atrial contraction,”Circulation Research. 52(6):657-663.
Morady, F. et al., (1990) “Effects of resting vagal tone on accessory atrioventricular connections,”Circulation81(1):86-90.
Randall, W. et al., (1977) “Neural Regulation of the Heart,”Oxford University Presspp. 100-106.
Stramba-Badiale, M. et al., (1991)“Sympathetic-Parasympathetic Interaction and Accentuated Antagonism in Conscious Dogs,”American Journal of Physiology260 (2Pt 2):H335-340.
Svedjeholm, R. et al., (2000) “Predictors of atrial fibrillation in patients undergoing surgery for ischemic heart disease,” Scandanavian.Cardiovascular Journal34:516-21.
Takei, M. et al., (2001)“Vagal stimulation prior to atrial rapid pacing protects the atrium from electrical remodeling in anesthetized dogs,”Japanese CirculationJournal 65(12):1077-81.
Takayama, S. et al., (2001) “A possible involvement of parasympathetic neuropathy on insulin resistance in patients with type 2 diabetes,”Diabetes Care24(5):968-969.
Vanoli, E. et al., (1991) “Vagal stimulation and prevention of sudden death in conscious dogs with a healed myocardial infarction,”Circulation Research68(5): 1471-1481.
Wang, H. et al., (Jan. 23, 2003) “Nicotinic acetylcholine receptor alpha-7 subunit is an essential regulator of inflammation,”Nature421:384-388.
Waninger, M. et al., (2000)“Electrophysiological control of ventricular rate during atrial fibrillation,”PACE23:1239-1244.
Wijffels, M. et al., (1995) “Atrial fibrillation begets atrial fibrillation,”Circulation92:1954-1968.
Zhang, Y. et al., (2002) “Optimal ventricular rate slowing during atrial fibrillation by feedback AV nodal-selective vagal stimulation,”American Journal of Physiology and Heart Circulatory and Physiology282:H11O2-H1110.
Oct. 29, 2007 Final Office Action issued in connection with U.S. Appl. No. 10/866,601.
Schaldach, M., (1992) “New Concepts in Electrotherapy of the Heart,” Electrotherapy of the Heart, Springer Verlag Heidelberg: 210-214.
Office Action, issued Jun. 24, 2009, in connection with U.S. Appl. No. 11/978,379, filed Oct. 29, 2007.
Office Action, issued Aug. 21, 2009, in connection with U.S. Appl. No. 11/975,240, filed Oct. 17, 2007.
Office Action, issued Aug. 25, 2009, in connection with U.S. Appl. No. 11/975,241, filed Oct. 17, 2007.
Morillo et al., “Chronic Rapid Atrial Pacing. Structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation,”Circulation, 1995, 91(5), 1588-1595.
Office Action, issued Feb. 5, 2010, in connection with U.S. Appl. No. 11/974,951, filed Oct. 16, 2007.
Office Action, issued Oct. 12, 2010 in connection with U.S. Appl. No. 11/974,951, filed Oct. 16, 2007.
Office Action, issued Oct. 27, 2010 in connection with U.S. Appl. No. 11/977,291, filed Oct. 23, 2007.
U.S. non-final Office Action for corresponding U.S. Appl. No. 11/974,951 mailed Feb. 4, 2011.
Ben-David Tamir
Ben-Ezra Omry
Cohen Ehud
Bio Control Medical (B.C.M.) Ltd.
Layno Carl H
Malamud Deborah
Sughrue & Mion, PLLC
LandOfFree
Parasympathetic pacing therapy during and following a... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Parasympathetic pacing therapy during and following a..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Parasympathetic pacing therapy during and following a... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4295470